Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray

BACKGROUND: Major depressive disorder (MDD) directly impacts patients’ lives including symptoms, functioning and health-related quality-of-life (HRQoL). Patient-reported outcomes can capture these impacts, however interpretation of clinical meaningfulness of these measurements are often not readily...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozjabek, Heather, Li, Nan, Hartmann, Holger, Fu, Dong Jing, Canuso, Carla, Jamieson, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273809/
https://www.ncbi.nlm.nih.gov/pubmed/35816217
http://dx.doi.org/10.1186/s41687-022-00453-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273809/
https://www.ncbi.nlm.nih.gov/pubmed/35816217
http://dx.doi.org/10.1186/s41687-022-00453-y

Ejemplares similares